Neurocrine Biosciences, Inc. announced that its collaboration partner, Mitsubishi Tanabe Pharma Corporation (MTPC), obtained regulatory approval of DYSVAL® capsules 40 mg (valbenazine) for the...
Rejuvenate Biomed NV ("Rejuvenate"), a biomedical company developing novel combination drugs for age-related diseases, provides an update on its development pipeline and strategy.
Also Read:...
The U.S. Food and Drug Administration (FDA) announced that Bravo Packing, Inc., an animal food manufacturing company of Carney's Point, New Jersey, has agreed...
HepaTx, a biotechnology company focused on innovative off-the-shelf cell therapies to treat late-stage liver disease, announced the Decision to Grant Patent protection by the...
TMRW Life Sciences, Inc. (TMRW), creator of the world's first and only automated specimen management platform for frozen eggs and embryos used for in...
